Pancreatic Cancer – Symptoms, Diagnosis & Cell Therapy Options at RCERT

Pancreatic cancer is one of the most challenging and aggressive cancers, known for its silent progression and late-stage detection. Often called a “silent killer,” pancreatic cancer typically shows few symptoms until it has advanced, making early diagnosis and intervention critical.

At RCERT (Regional Cell Research & Therapy Centre), we integrate cutting-edge technologies like cell therapy, immunotherapy, and regenerative medicine to support better outcomes for pancreatic cancer patients. Our therapies are developed through collaborations with UNIMAS and Zhongrong Cell Technology Center (China) to bring advanced solutions to Malaysia and the Southeast Asian region.

🧬 What Is Pancreatic Cancer?

Pancreatic cancer begins in the tissues of the pancreas, an organ located behind the stomach that plays a crucial role in digestion and hormone production. The most common type is pancreatic ductal adenocarcinoma, which starts in the ducts that carry digestive enzymes.

Other less common types include neuroendocrine tumors and ampullary cancer.

📈 Global & Regional Statistics

• Globally: Pancreatic cancer is the 7th leading cause of cancer death worldwide.

• Survival Rate: The 5-year survival rate remains low — around 11% overall.

• In Malaysia: Cases are rising steadily, particularly in aging populations and those with diabetes or metabolic disorders.

⚠️ Symptoms of Pancreatic Cancer

Pancreatic cancer is difficult to detect early due to non-specific symptoms. Common warning signs include:

• Persistent abdominal pain or discomfort

• Unexplained weight loss

• Jaundice (yellowing of the skin and eyes)

• Dark urine and pale stools

• Loss of appetite

• Nausea or vomiting

• Fatigue

• New-onset diabetes or sudden blood sugar fluctuations

By the time symptoms become obvious, the cancer has often spread to nearby tissues or organs.

🧪 Risk Factors

Several factors may increase the risk of developing pancreatic cancer:

• Age (more common after age 60)

• Chronic pancreatitis

• Smoking

• Obesity

• Diabetes

• Family history or genetic mutations (e.g., BRCA2, Lynch syndrome)

• High red meat or processed food consumption

• Heavy alcohol use

🧫 How Is Pancreatic Cancer Diagnosed?

Early diagnosis is key to improving survival. RCERT collaborates with diagnostic centers and specialists to provide:

• Blood tests: CA19-9 tumor marker

• Imaging: CT scan, MRI, PET-CT

• Endoscopic ultrasound (EUS): For tumor localization

• Biopsy: Tissue confirmation via fine-needle aspiration

• Genomic profiling: Optional tests for precision therapy matching

Patients with high genetic risk or family history may also benefit from preventive health screening programs at RCERT.

🎯 Staging & Treatment Options

Pancreatic cancer is categorized into stages 0 to IV. Treatment depends on the stage at diagnosis:

• Surgical Resection (Whipple Procedure): Best for early-stage tumors

• Chemotherapy: Common drugs include FOLFIRINOX or gemcitabine

• Radiotherapy: May be used before or after surgery

• Targeted Therapy: For tumors with specific gene mutations

• Immunotherapy & Cell Therapy: Emerging options for advanced and relapsed cases

🧬 RCERT’s Cell Therapy Approach for Pancreatic Cancer

At RCERT, we are developing personalized immunotherapy and regenerative solutions for pancreatic cancer using:

✅ Dendritic Cells (DC)

• Loaded with pancreatic tumor antigens to train T cells

• Initiates adaptive anti-tumor immune response

✅ Cytokine-Induced Killer (CIK) Cells

• Broad-spectrum cytotoxic cells

• Non-MHC restricted — effective even when tumor evades immune system

✅ DC-CIK Combination Therapy

• Enhances immune targeting

• Boosts overall immune engagement and tumor response

✅ CAR-T and DC-CTL (Research Pipeline)

• For highly resistant or relapsed cases

✅ Exosomes & MSCs (Supportive Use)

• Reduce inflammation, promote recovery, and reduce chemo side effects

Our therapies are processed under GMP-certified laboratories and personalized to each patient’s tumor profile, stage, and treatment history.

🤝 Why Choose RCERT?

• Multi-disciplinary Team: Physicians, immunologists, and cell scientists

• Regional Expertise: Focus on cancers common in Malaysia and Southeast Asia

• Technology Transfer from China: Collaboration with Zhongrong Cell Technology Center

• Integrated Wellness Programs: Anti-aging, DNA methylation testing, IV immune support

• Clinical Site at UNIMAS Sarawak: For research, trials, and personalized treatment

⚖️ Safety & Effectiveness

Cell therapies like DC-CIK and DC-CTL are generally well-tolerated with minimal side effects, especially when compared to chemotherapy. Common mild reactions include:

• Fatigue

• Mild fever

• Injection site inflammation

• Transient flu-like symptoms

Each case is carefully evaluated by our clinical team to ensure maximum safety and benefit.

👨‍⚕️ Who Is Eligible for RCERT Pancreatic Cancer Programs?

You may qualify for RCERT’s personalized cancer immunotherapy if you:

• Have been diagnosed with pancreatic cancer, especially stage II–IV

• Are currently undergoing or have completed chemotherapy

• Seek complementary therapy to boost immunity and prevent recurrence

• Have relapsed or are chemotherapy-resistant

• Are open to investigational cell therapy protocols

A full medical consultation, diagnostic review, and blood profiling are required before treatment planning.

🌱 Recovery & Support Services

RCERT provides a holistic care model that includes:

• Nutritional guidance for pancreatic health

• Detoxification and immune-boosting IV therapy

• DNA methylation age testing for recovery monitoring

• Supportive care with supplements and mitochondrial health programs

• Psychological and family counseling support

We are committed to whole-person care, not just tumor control.

📝 Conclusion

Pancreatic cancer is one of the most complex and deadly forms of cancer — but new hope is emerging through cellular immunotherapy and precision medicine. At RCERT, we are pioneering a new standard of care by integrating dendritic cells, CIK cells, exosomes, and genomic insight into personalized treatment pathways.

Whether you are newly diagnosed, undergoing treatment, or looking for recurrence prevention, RCERT is here to help you with expertise, innovation, and compassion.

📞 Book a consultation today to learn how our pancreatic cancer cell therapy programs may benefit you.